ATE309221T1 - Trizyklo-imidazolinen derivaten, verfahren zu deren herstellung und deren verwendung als heilmitteln - Google Patents
Trizyklo-imidazolinen derivaten, verfahren zu deren herstellung und deren verwendung als heilmittelnInfo
- Publication number
- ATE309221T1 ATE309221T1 AT03739537T AT03739537T ATE309221T1 AT E309221 T1 ATE309221 T1 AT E309221T1 AT 03739537 T AT03739537 T AT 03739537T AT 03739537 T AT03739537 T AT 03739537T AT E309221 T1 ATE309221 T1 AT E309221T1
- Authority
- AT
- Austria
- Prior art keywords
- sub
- trizyklo
- remedies
- production
- imidazoline derivatives
- Prior art date
Links
- 229940083254 peripheral vasodilators imidazoline derivative Drugs 0.000 title 1
- 150000003839 salts Chemical class 0.000 abstract 2
- 125000003118 aryl group Chemical group 0.000 abstract 1
- 125000002915 carbonyl group Chemical group [*:2]C([*:1])=O 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 150000004677 hydrates Chemical class 0.000 abstract 1
- 229910052500 inorganic mineral Inorganic materials 0.000 abstract 1
- 239000011707 mineral Substances 0.000 abstract 1
- 150000007522 mineralic acids Chemical class 0.000 abstract 1
- 150000007524 organic acids Chemical class 0.000 abstract 1
- 235000005985 organic acids Nutrition 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C69/00—Esters of carboxylic acids; Esters of carbonic or haloformic acids
- C07C69/74—Esters of carboxylic acids having an esterified carboxyl group bound to a carbon atom of a ring other than a six-membered aromatic ring
- C07C69/757—Esters of carboxylic acids having an esterified carboxyl group bound to a carbon atom of a ring other than a six-membered aromatic ring having any of the groups OH, O—metal, —CHO, keto, ether, acyloxy, groups, groups, or in the acid moiety
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/04—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
- C07D233/06—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, directly attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/04—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
- C07D233/20—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with substituted hydrocarbon radicals, directly attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/04—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
- C07D233/20—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with substituted hydrocarbon radicals, directly attached to ring carbon atoms
- C07D233/22—Radicals substituted by oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2603/00—Systems containing at least three condensed rings
- C07C2603/02—Ortho- or ortho- and peri-condensed systems
- C07C2603/04—Ortho- or ortho- and peri-condensed systems containing three rings
- C07C2603/06—Ortho- or ortho- and peri-condensed systems containing three rings containing at least one ring with less than six ring members
- C07C2603/10—Ortho- or ortho- and peri-condensed systems containing three rings containing at least one ring with less than six ring members containing five-membered rings
- C07C2603/12—Ortho- or ortho- and peri-condensed systems containing three rings containing at least one ring with less than six ring members containing five-membered rings only one five-membered ring
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Psychology (AREA)
- Hospice & Palliative Care (AREA)
- Psychiatry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR0201839A FR2835834B1 (fr) | 2002-02-14 | 2002-02-14 | Nouveaux derives de tricyclo-imidazolines, leur procede de preparation et leur utilisation a titre de medicaments |
| PCT/FR2003/000480 WO2003068755A1 (fr) | 2002-02-14 | 2003-02-14 | Nouveaux derives de tricyclo-imidazolines, leur procede de preparation et leur utilisation a titre de medicaments |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE309221T1 true ATE309221T1 (de) | 2005-11-15 |
Family
ID=27620209
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT03739537T ATE309221T1 (de) | 2002-02-14 | 2003-02-14 | Trizyklo-imidazolinen derivaten, verfahren zu deren herstellung und deren verwendung als heilmitteln |
Country Status (13)
| Country | Link |
|---|---|
| US (1) | US20050107455A1 (de) |
| EP (1) | EP1476433B1 (de) |
| JP (1) | JP2005525342A (de) |
| CN (1) | CN1646496A (de) |
| AT (1) | ATE309221T1 (de) |
| AU (1) | AU2003226482A1 (de) |
| BR (1) | BR0307671A (de) |
| CA (1) | CA2475880A1 (de) |
| DE (1) | DE60302217D1 (de) |
| FR (1) | FR2835834B1 (de) |
| MX (1) | MXPA04007856A (de) |
| WO (1) | WO2003068755A1 (de) |
| ZA (1) | ZA200406445B (de) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP2323734A1 (de) * | 2008-08-04 | 2011-05-25 | Schering Corporation | Cyclopropylchromen-derivate als modulatoren des alpha-2c-rezeptors |
| CN103360360A (zh) * | 2012-04-10 | 2013-10-23 | 肖竹平 | 一种基于二氢杨梅素制备(+)-没食子儿茶素的方法 |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| PT1280779E (pt) * | 2000-05-08 | 2005-11-30 | Orion Corp | Novos indanilimidazois policiclicos com actividade adrenergica alfa2 |
-
2002
- 2002-02-14 FR FR0201839A patent/FR2835834B1/fr not_active Expired - Fee Related
-
2003
- 2003-02-14 JP JP2003567886A patent/JP2005525342A/ja active Pending
- 2003-02-14 CA CA002475880A patent/CA2475880A1/fr not_active Abandoned
- 2003-02-14 AT AT03739537T patent/ATE309221T1/de not_active IP Right Cessation
- 2003-02-14 DE DE60302217T patent/DE60302217D1/de not_active Expired - Lifetime
- 2003-02-14 EP EP03739537A patent/EP1476433B1/de not_active Expired - Lifetime
- 2003-02-14 AU AU2003226482A patent/AU2003226482A1/en not_active Abandoned
- 2003-02-14 MX MXPA04007856A patent/MXPA04007856A/es unknown
- 2003-02-14 US US10/504,642 patent/US20050107455A1/en not_active Abandoned
- 2003-02-14 BR BR0307671-7A patent/BR0307671A/pt not_active Application Discontinuation
- 2003-02-14 CN CNA038080923A patent/CN1646496A/zh active Pending
- 2003-02-14 WO PCT/FR2003/000480 patent/WO2003068755A1/fr active IP Right Grant
-
2004
- 2004-08-13 ZA ZA200406445A patent/ZA200406445B/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| CA2475880A1 (fr) | 2003-08-21 |
| DE60302217D1 (de) | 2005-12-15 |
| MXPA04007856A (es) | 2004-10-15 |
| US20050107455A1 (en) | 2005-05-19 |
| EP1476433A1 (de) | 2004-11-17 |
| JP2005525342A (ja) | 2005-08-25 |
| AU2003226482A1 (en) | 2003-09-04 |
| FR2835834B1 (fr) | 2004-04-02 |
| BR0307671A (pt) | 2005-01-04 |
| ZA200406445B (en) | 2005-06-14 |
| FR2835834A1 (fr) | 2003-08-15 |
| CN1646496A (zh) | 2005-07-27 |
| WO2003068755A1 (fr) | 2003-08-21 |
| EP1476433B1 (de) | 2005-11-09 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MEP7808A (en) | Process for preparing 4-trifluoromethylsulphinylpyrazole derivative | |
| ATE533775T1 (de) | Verfahren zur herstellung von 17-vinyl-triflaten als intermediate | |
| RS51983B (en) | SYNTHESIS OF ORGANOBORIC ACID AND ORGANOBORIC ACID COMPOUNDS | |
| RS20050182A (en) | Derivatives of dioxane-2-alkyl carbamates,preparation method thereof and application of same in therapeutics | |
| DE60123911D1 (de) | Verfahren zur Herstellung von Aryloctanoyl-amiden | |
| BRPI0406500A (pt) | processo farmacêutico e compostos preparados pelo mesmo | |
| EA200300927A1 (ru) | Новый способ промышленного синтеза тетрасложных эфиров 5-[бис(карбоксиметил)амино]-3-карбоксиметил-4-циано-2-тиофенкарбоновой кислоты и применение для синтеза бивалентных солей ранелиновой кислоты и их гидратов | |
| ATE495158T1 (de) | Substituierte tetrahydroisochinoline als mmp- inhibitoren, verfahren zu ihrer herstellung und ihre verwendung als medikament | |
| AR058178A1 (es) | Preventivos remedios para trastornos urinarios | |
| WO2008149834A1 (ja) | ピリミドジアゼピノン誘導体 | |
| WO2008068423A3 (fr) | Derives de pyrrole, leur preparation et leur utilisation en therapeutique. | |
| TW200602810A (en) | High molecular weight compound, photoresist composition containing the compound and formation method for photoresist pattern | |
| ATE442849T1 (de) | Wässrige zusammensetzung mit einem thiazol- derivat | |
| ATE286050T1 (de) | Heterozyclische oder benzol derivate von liponsäure, deren herstellung und deren verwendung als heilmittel | |
| ATE309221T1 (de) | Trizyklo-imidazolinen derivaten, verfahren zu deren herstellung und deren verwendung als heilmitteln | |
| ATE304004T1 (de) | Verfahren zur herstellung von 2-alkyl-3- aminothiophen derivate und 3-aminothiophen derivate | |
| HRP20030381B1 (en) | 3-DECLADINOZYL 9a-N-CARBAMOYL AND 9a-N-THIOCARBAMOYL DERIVATIVES 9-DEOXO-9-DIHYDRO-9a-AZA-9a-HOMOERYTHROMICYNE A | |
| DE60323748D1 (de) | 1,3-diaza-dibenzoazulene als inhibitoren der produfür deren herstellung | |
| EA200600608A1 (ru) | Производные имидазопиридина как ингибиторы индуцируемой no-синтазы | |
| EA200500237A1 (ru) | Новый способ синтеза соединений 1,3-дигидро-2h-3-бензазепин-2-она и применение при синтезе ивабрадина и его солей присоединения с фармацевтически приемлемой кислотой | |
| TW200728264A (en) | New compound, acid genelator, chemically amplified photoresist composition, resist laminate, and process for forming resist pattern | |
| DE60321724D1 (de) | 1,2-diaza-dibenzoazulene als inhibitoren der produfür deren herstellung | |
| AR041451A1 (es) | Nuevo polimero de nitrosacion en sintesis organica | |
| ATE340175T1 (de) | Imidazo(4,5-böchinolinderivate und ihre verwendung als inhibitoren der induzierbaren no- synthase | |
| ATE428690T1 (de) | Salz, welches für einen sauergenerator geeignet ist, sowie chemisch verstärkte resistzusammensetzung, die dieses enthält |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |